NEYLAND PHARMACY LIMITEDActive
Key figures
Ratios
2025/26Balance sheet structure
Filed accounts2019/20–2025/26
| 2021/22 | 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | 1,044,052 |
| Profit for the year | — | — | — | — | 104,703 |
| Cash at bank and in hand | 122,607 | 117,883 | 138,256 | 113,286 | 130,040 |
| Total assets | 336,246 | 327,247 | 342,104 | 302,427 | 321,324 |
| Total liabilities | 216,235 | 211,137 | 224,990 | 194,885 | 198,418 |
| Net assets / total equity | 224,456 | 224,558 | 219,626 | 219,019 | 227,722 |
| Average number of employees | 8 | 8 | 8 | 8 | 8 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: NEYLAND PHARMACY LIMITED
Company
NEYLAND PHARMACY LIMITED is a private limited company registered with Companies House under company number 05014714. It was incorporated on 14 Jan 2004. Its status is active. The registered office is in Milford haven (SA73). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730), other retail sale of new goods in specialised stores (not commercial art galleries and opticians) (47789), buying and selling of own real estate (68100).
Accounts
The latest accounts in the database are for 2025/26 (period ending 31 Jan 2026); the company files small company accounts (filleted). Turnover was £1,044,052. Profit for the year was £104,703. Net assets were £227,722, up 4% on the previous year. Cash at bank and in hand was £130,040. Total assets were £321,324 and total liabilities £198,418. The company had an average of 8 employees. Figures are available for 7 financial years (2019/20–2025/26).
Control and charges
The company has 2 current directors. 2 persons with significant control are registered. 1 of 2 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Oct 2027. The next confirmation statement is due by 13 Aug 2027.